drugset / Trial / NCT00964431
Phase 2 Study of Indomethacin Capsules to Treat Dental Pain
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether Indomethacin Test Formulation Capsules are safe and effective for the treatment of dental pain.
Timeline
- Start
- 2009-08
- Primary completion
- 2009-12
- Completion
- 2009-12
Outcome
Met primary endpoint
registry analysis (superiority or other test); Indomethacin Test (Upper Dose) vs Placebo; p <0.001; Mean Difference (Net) 9.545 (95% CI 5.816 to 13.275); ANCOVA NCT00964431 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 400 mg | — |
| Subject | Indomethacin | Small molecule | 20 mg | — |
| Subject | Indomethacin | Small molecule | 40 mg | — |
Indications
No indication recorded.